Biomarkers as Predictors of Chronic Heart Failure in Patients With Type 2 Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorRegionshospital Nordjylland
About this trial
A cohort study on patients with type 2 diabetes to investigate possible biomarkers as predictors of chronic heart failure.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Type 2 diabetes
age > 50 years
Disqualifiers
History of acute or chronic heart failure
History of ischemic heart disease
Trial population
500 patients with known type 2 diabetes who are treated at the department of endocrinology, North Denmark Regional Hospital.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Chronic Heart Failure
Determined by echocardiography according to European Society of Cardiology (ESC) definitions
Time frame
During 5 year follow upSecondary outcomes
1
NT-ProBNP
Change in N-terminal prohormone of brain natriuretic peptide (NT-ProBNP)
Time frame
During 5 year follow up2
hs-CRP
Change in High-sensitivity C-reactive protein (hs-CRP)
Time frame
During 5 year follow up3
Troponin
Change in Troponin
Time frame
During 5 year follow up4
6 minutes walk test
Change in 6 minutes walk test
Time frame
During 5 year follow upOther outcomes
1
HOMA-IR
Change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
Time frame
During 5 year follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov